A synthetic PGC1α co-activator reprograms microglial immunometabolism to preserve cone function in retinal degeneration.
Winogrodzki T, Hernandez-Reyes J, Solanky R, Lowery R, Komissarov G, Huang W, Wang B, Makrides N, Davis S, Liu S, Li YS, Wu WH, Nolan N, van de Werken R, Demirkol A, Knudsen A, Surawatsatien N, Li Y, Hurley J, Tsang SH
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.